There are ongoing efforts to reverse the Medicare ban on obesity treatments, including advocacy in favor of the Treat and Reduce Obesity Act of 2023 (TROA), a scaled-back version of which recently passed out of the House Ways and Means Committee
In October 2024, Novo Nordisk formally asked the FDA to ban the production of compounded semaglutide and requested that the agency move the drug to its Demonstrable Difficulties for Compounding (DDC) list
While on the medication, she established healthier eating habits and incorporated excerise into her routine
These medications, which are offered through our personalized programs (when prescribed by a medical professional), help regulate blood sugar, reduce appetite, and promote feelings of fullness
Our team prescribes Wegovy, Oral Wegovy, Zepbound, and Foundayo for their FDA-approved weight management indications